These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
491 related articles for article (PubMed ID: 26564387)
1. Cataplexy with Normal Sleep Studies and Normal CSF Hypocretin: An Explanation? Drakatos P; Leschziner G J Clin Sleep Med; 2016 Mar; 12(3):449-50. PubMed ID: 26564387 [TBL] [Abstract][Full Text] [Related]
3. A study of the diagnostic utility of HLA typing, CSF hypocretin-1 measurements, and MSLT testing for the diagnosis of narcolepsy in 163 Korean patients with unexplained excessive daytime sleepiness. Hong SC; Lin L; Jeong JH; Shin YK; Han JH; Lee JH; Lee SP; Zhang J; Einen M; Mignot E Sleep; 2006 Nov; 29(11):1429-38. PubMed ID: 17162989 [TBL] [Abstract][Full Text] [Related]
4. Decreased CSF histamine in narcolepsy with and without low CSF hypocretin-1 in comparison to healthy controls. Nishino S; Sakurai E; Nevsimalova S; Yoshida Y; Watanabe T; Yanai K; Mignot E Sleep; 2009 Feb; 32(2):175-80. PubMed ID: 19238804 [TBL] [Abstract][Full Text] [Related]
5. Symptomatic narcolepsy, cataplexy and hypersomnia, and their implications in the hypothalamic hypocretin/orexin system. Nishino S; Kanbayashi T Sleep Med Rev; 2005 Aug; 9(4):269-310. PubMed ID: 16006155 [TBL] [Abstract][Full Text] [Related]
7. Narcolepsy without cataplexy: 2 subtypes based on CSF hypocretin-1/orexin-A findings. Oka Y; Inoue Y; Kanbayashi T; Kuroda K; Miyamoto M; Miyamoto T; Ikeda A; Shimizu T; Hishikawa Y; Shibasaki H Sleep; 2006 Nov; 29(11):1439-43. PubMed ID: 17162990 [TBL] [Abstract][Full Text] [Related]
8. Predictors of hypocretin (orexin) deficiency in narcolepsy without cataplexy. Andlauer O; Moore H; Hong SC; Dauvilliers Y; Kanbayashi T; Nishino S; Han F; Silber MH; Rico T; Einen M; Kornum BR; Jennum P; Knudsen S; Nevsimalova S; Poli F; Plazzi G; Mignot E Sleep; 2012 Sep; 35(9):1247-55F. PubMed ID: 22942503 [TBL] [Abstract][Full Text] [Related]
9. The role of cerebrospinal fluid hypocretin measurement in the diagnosis of narcolepsy and other hypersomnias. Mignot E; Lammers GJ; Ripley B; Okun M; Nevsimalova S; Overeem S; Vankova J; Black J; Harsh J; Bassetti C; Schrader H; Nishino S Arch Neurol; 2002 Oct; 59(10):1553-62. PubMed ID: 12374492 [TBL] [Abstract][Full Text] [Related]
10. Validation of the ICSD-2 criteria for CSF hypocretin-1 measurements in the diagnosis of narcolepsy in the Danish population. Knudsen S; Jennum PJ; Alving J; Sheikh SP; Gammeltoft S Sleep; 2010 Feb; 33(2):169-76. PubMed ID: 20175400 [TBL] [Abstract][Full Text] [Related]
11. Progressive narcolepsy: how to deal with intermediate hypocretin-1 values? Ricordeau F; Bridoux A; Raverot V; Peter-Derex L J Clin Sleep Med; 2023 Jul; 19(7):1375-1378. PubMed ID: 37066739 [TBL] [Abstract][Full Text] [Related]
12. Hypocretin deficiency develops during onset of human narcolepsy with cataplexy. Savvidou A; Knudsen S; Olsson-Engman M; Gammeltoft S; Jennum P; Palm L Sleep; 2013 Jan; 36(1):147-8. PubMed ID: 23288981 [TBL] [Abstract][Full Text] [Related]
13. Temporal Changes in the Cerebrospinal Fluid Level of Hypocretin-1 and Histamine in Narcolepsy. Lopez R; Barateau L; Evangelista E; Chenini S; Robert P; Jaussent I; Dauvilliers Y Sleep; 2017 Jan; 40(1):. PubMed ID: 28364477 [TBL] [Abstract][Full Text] [Related]
14. Intermediate hypocretin-1 cerebrospinal fluid levels and typical cataplexy: their significance in the diagnosis of narcolepsy type 1. van der Hoeven AE; Fronczek R; Schinkelshoek MS; Roelandse FWC; Bakker JA; Overeem S; Bijlenga D; Lammers GJ Sleep; 2022 May; 45(5):. PubMed ID: 35554594 [TBL] [Abstract][Full Text] [Related]
15. Hypocretin (orexin) deficiency in narcolepsy and primary hypersomnia. Ebrahim IO; Sharief MK; de Lacy S; Semra YK; Howard RS; Kopelman MD; Williams AJ J Neurol Neurosurg Psychiatry; 2003 Jan; 74(1):127-30. PubMed ID: 12486284 [TBL] [Abstract][Full Text] [Related]